Generally speaking, isn't the experience sufficient to provide some insight on the wisdom of providing a lot of additional power and leverage to private multinational companies over and above governments that are democratically elected and expected to regulate in the public interest, in the context of these agreements? I think the vaccine rollout is a clear example of how the additional power that's been conferred on private companies, within agreements like this, can be at odds with the public interest.
Isn't an obvious conclusion from this that Canada should be a lot more wary than it has been in the past about solidifying the power that those companies enjoy within our international trade agreements?